Astellas Pharma Inc. announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending approval of Xtandi (enzalutamide) as monotherapy or in combination with androgen deprivation therapy for the treatment of adult men with high risk biochemical recurrent (BCR) non-metastatic hormone sensitive prostate cancer (nmHSPC) who are unsuitable for salvage radiotherapy.
This literature review and meta-analysis aimed to determine the association between deficiency of vitamin D, or 25-hydroxyvitamin D, and Parkinson's disease, and whether vitamin D from supplements and sunlight...
Signifor (pasireotide)from Novartis, significantly reduced urinary cortisol levels and improved symptoms of Cushing's disease in the largest clinical study of...
Protagonist Therapeutics, Inc. announced it has randomized 241 patients in the ongoing Phase III VERIFY clinical trial evaluating rusfertide in polycythemia vera ("PV") as and expects to meet the trial's 250 patient enrollment target by the end of March 2024
New results from the MADIT-RIT clinical trial demonstrated improved programming of Boston Scientific dual-chamber implantable cardioverter defibrillator (S-ICD) or cardiac...
A report in 2 August issue of NEJM recorded that a combination of Arimidex ( anastrozole) and oestrogen receptor modulator...
Background: Vitamin D has been reported to be associated with many allergic diseases. There are a limited number of the studies of vitamin D supplementation in patients with chronic spontaneous urticaria (CSU). U).
BeiGene, Ltd. announced that the FDA has approved Tevimbra (tislelizumab-jsgr) as monotherapy for the treatment of adult patients with unresectable or metastatic esophageal squamous cell carcinoma (ESCC) after prior systemic chemotherapy that did not include a PD-(L)1 inhibitor . Tevimbra will be available in the U.S. in the second half of 2024.
The FDA has approved Medtronic Amplia MRI Quad CRT-D SureScan and Compia MRI Quad CRT-D SureScan systems for the treatment...
Background: There is growing literature suggesting a link between vitamin D and asthma lung function, but the results from systematic reviews are conflicting.